Multinucleate giant cells release functionally unopposed matrix metalloproteinase-9 in vitro and in vivo

J Infect Dis. 2007 Oct 1;196(7):1076-9. doi: 10.1086/521030. Epub 2007 Aug 20.

Abstract

Multinucleated giant cells (MGCs) are characteristic of granulomatous inflammation. Matrix metalloproteinase (MMP)-9, the major monocyte-derived matrix metalloproteinase, is key in inflammatory tissue damage. At 72 h, MGCs secrete 153 +/- 2.5 ng/mL MMP-9, compared with 115 +/- 3.8 ng/mL during macrophage differentiation (P<.05). In contrast, the level of MGC secretion-specific tissue inhibitor, tissue inhibitor of metalloproteinase (TIMP)-1, is lower (P<.05). Mature MGCs secrete constitutively greater concentrations of MMP-9 than do monocytes or macrophages (P<.05). MGCs in tuberculous lymph-node biopsy samples express high MMP-9 levels adjacent to areas of necrosis, whereas TIMP-1 is not detected. Thus, MGCs are potentially important sources of MMP-9 secretion and may contribute to inflammatory tissue damage in human tuberculosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation
  • Cells, Cultured
  • Giant Cells / cytology*
  • Giant Cells / enzymology*
  • Giant Cells / immunology
  • Humans
  • Macrophages / cytology
  • Macrophages / immunology
  • Matrix Metalloproteinase 9* / metabolism
  • Matrix Metalloproteinase Inhibitors
  • Monocytes / cytology
  • Monocytes / immunology
  • Mycobacterium tuberculosis
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism
  • Tuberculoma* / immunology
  • Tuberculoma* / microbiology
  • Tuberculoma* / physiopathology
  • Tuberculosis, Lymph Node* / immunology
  • Tuberculosis, Lymph Node* / microbiology
  • Tuberculosis, Lymph Node* / physiopathology

Substances

  • Matrix Metalloproteinase Inhibitors
  • Tissue Inhibitor of Metalloproteinase-1
  • Matrix Metalloproteinase 9